chr1-15770553-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_017556.4(FBLIM1):c.686G>A(p.Arg229Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000161 in 1,613,932 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_017556.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FBLIM1 | NM_017556.4 | c.686G>A | p.Arg229Gln | missense_variant | 6/9 | ENST00000375766.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FBLIM1 | ENST00000375766.8 | c.686G>A | p.Arg229Gln | missense_variant | 6/9 | 2 | NM_017556.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000184 AC: 28AN: 152148Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000837 AC: 21AN: 250896Hom.: 0 AF XY: 0.0000958 AC XY: 13AN XY: 135748
GnomAD4 exome AF: 0.000159 AC: 232AN: 1461666Hom.: 0 Cov.: 33 AF XY: 0.000155 AC XY: 113AN XY: 727146
GnomAD4 genome AF: 0.000184 AC: 28AN: 152266Hom.: 0 Cov.: 31 AF XY: 0.000134 AC XY: 10AN XY: 74444
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 09, 2021 | The c.686G>A (p.R229Q) alteration is located in exon 5 (coding exon 4) of the FBLIM1 gene. This alteration results from a G to A substitution at nucleotide position 686, causing the arginine (R) at amino acid position 229 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at